Breadcrumb Home IMPAACT News IMPAACT News News October 2024 Announcements Call for Self-Nominations: IMPAACT Network Co-Chair October 2024 Announcements IMPAACT Network Chair Key Contributor to Updated WHO Clinical Trial Guidance July 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data Search Enter a search term. Filter Topics AllAnnouncementsMeetingsSpotlight SeriesStudy Results Date All202420232022202120202019201820162014 Sort Date AscDate Desc Submit Search Showing 89 news items. September 2020 Meetings Key Dates for CROI 2021 June 2020 Study Results IMPAACT P1093 Informs FDA Decision to Approve First-ever Dolutegravir Dispersible Tablet for Treatment of Children living with HIV June 2020 Announcements Statement from IMPAACT Leadership on Longstanding Racial Injustice March 2020 Meetings COVID-19 Resources March 2020 Study Results IMPAACT 2001 Primary Results Released March 2020 Study Results IMPAACT 2010 Primary Results Released March 2020 Study Results IMPAACT 2009 PK Results Released February 2020 Announcements IMPAACT 2016 Expert Trainer Training Underway December 2019 Study Results Results from P1104s published in Clinical Infectious Diseases October 2019 Study Results Primary results from the IMPAACT P1078/TB APPRISE study published Pagination Previous page Prev Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Next page Next
October 2024 Announcements IMPAACT Network Chair Key Contributor to Updated WHO Clinical Trial Guidance
July 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data
June 2020 Study Results IMPAACT P1093 Informs FDA Decision to Approve First-ever Dolutegravir Dispersible Tablet for Treatment of Children living with HIV
